1. BfArM 2004 Erläuterungen zum Vorgehen bei der Beurteilung von in vitro Untersuchungen Pharmakokinetischer Interaktionen mit Phytopharmaka Bundesinstitut für Arzneimittelsicherheit Berlin
2. Berlin 1997 Committee for Proprietary Medicinal Products: Note for Guidance on the Investigation of Drug Interactions The European Agency for the Evaluation of Medicinal Products, Human Medicines Evaluation Unit London
3. In vitro inhibition of CYP3A4 by herbal remedies frequently used by cancer patients;Engdal;Phytother Res,2009
4. FDA 2006 Guidance for Industry: Drug interaction Studies and implication for Dosing and Labelling FDA Washington
5. Pharmacokinetics of natural mistletoe lectins after subcutaneous injection;Huber;Eur J Clin Pharmacol,2010